172 related articles for article (PubMed ID: 38524129)
1. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
He R; Guan C; Zhao X; Yu L; Cui Y
Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q
Front Immunol; 2024; 15():1335112. PubMed ID: 38476236
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
4. Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis.
Meng Q; Li X; Xiong X
Front Genet; 2022; 13():872518. PubMed ID: 35559030
[No Abstract] [Full Text] [Related]
5. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
7. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
8. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
9. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.
Ma M; Xie W; Li X
Int J Gen Med; 2021; 14():3163-3176. PubMed ID: 34262330
[TBL] [Abstract][Full Text] [Related]
10. Weighted Gene Co-Expression Network Analysis of Immune Infiltration in Nonalcoholic Fatty Liver Disease.
Wang Z; Xia Y; Pan Y; Zhang L; Tang F; Yu X; Yang Z; Wang D; Yang L; Jia J; Yuan G
Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1173-1185. PubMed ID: 36503447
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract][Full Text] [Related]
12. Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis.
Li X; Zhong S; Sun Y; Huang X; Li Y; Wang L; Wu Y; Yang M; Yuan HX; Liu J; Zang S
Front Endocrinol (Lausanne); 2022; 13():951093. PubMed ID: 36329886
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
14. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis.
Wang L; He W; Wang X; Wang J; Wei X; Wu D; Wu Y
Front Med (Lausanne); 2024; 11():1322102. PubMed ID: 38606153
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.
Luo Z; Yan S; Chao Y; Shen M
Heliyon; 2024 Apr; 10(7):e28935. PubMed ID: 38601640
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
[TBL] [Abstract][Full Text] [Related]
17. Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis.
Zhang JJ; Shen Y; Chen XY; Jiang ML; Yuan FH; Xie SL; Zhang J; Xu F
Front Endocrinol (Lausanne); 2023; 14():1115890. PubMed ID: 37008925
[TBL] [Abstract][Full Text] [Related]
18. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
[No Abstract] [Full Text] [Related]
19. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer.
Qiu T; Hu W; Rao Z; Fang T
Front Genet; 2022; 13():1007337. PubMed ID: 36568397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
